Stock TitanMAR 172 min read$BRBS

Blue Ridge Bankshares (BRBS) interim CEO discloses 210,039-share stake

Blue Ridge Bankshares' interim CEO and President, Harry W. Golliday, has disclosed an initial direct holding of 210,039 shares of common stock, as reported in a recent SEC Form 3 filing. This stake includes 160,000 unvested performance-based restricted stock awards, whose vesting is contingent upon company performance and a specific schedule. The filing provides transparency regarding the CEO's equity ownership without indicating any current buy or sell transactions.

Original reporting

Stock Titan

Published Mar 17, 2026, 1:38 AM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Mar 17, 2026, 2:00 AM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

alphai market briefFinancial news

Primary signal

$BRBS

Bullish

medium confidence

Mentioned

$BRBS

alphai data visualization · based on Stock Titan

Decision brief

The 30-second read

$BRBSBullishLow

Why it matters

This disclosure may influence investor confidence positively, but lacks evidence of recent trading activity.

Market read

Insider ownership disclosures are relevant for assessing management confidence but should be considered alongside other fundamental factors.

What to watch

The presence of unvested awards indicates potential future dilution; macroeconomic factors and company fundamentals should be considered.

Timing: Long-term relevance; immediate trading actions are not recommended.

Background

The SEC Form 3 filing discloses the CEO's initial beneficial ownership, providing transparency into insider holdings.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$BRBSBullishMedium confidence

Context

The disclosed shareholding by the CEO indicates a personal investment in Blue Ridge Bankshares, which could signal confidence in the company's future prospects.

Expected impact

Moderate upward movement expected in the short term, contingent on broader market conditions.

Evidence & confidence

While insider holdings can signal confidence, the lack of recent transactions and the presence of unvested awards introduce uncertainty.

Market effects

Sector

Potential positive sentiment for regional banking sector; limited broader market impact.

Regional

Minimal; specific to regional banking stocks.

Global

Negligible; company-specific insider activity.

Counterpoint

What could challenge this read

Insider holdings may not always translate into positive performance; could be a defensive or personal investment unrelated to company prospects.

Key entities

Person
Harry W. Golliday
Interim CEO and President of Blue Ridge Bankshares.
Company
Blue Ridge Bankshares
Regional banking institution.

Read at source ← All news

AUG 17

$BRBSMedAI 8/10

NC bank's latest deal fits its Atlanta-to-Richmond plan

HomeTrust Bancshares agreed to buy Blue Ridge Bankshares in an all-stock deal valued at about $448.1 million, expected to close in early Q1 2027. The transaction would nearly double HomeTrust’s branch network, lift assets to about $7 billion, and add about $1.9 billion each of loans and deposits. Blue Ridge exited regulatory issues tied to fintech partnerships.

americanbanker.com4 min

AUG 17

$BRBSMedAI 9/10

Blue Ridge Bankshares to Merge With HomeTrust in All-Stock Deal at 0.086 Exchange Ratio

Blue Ridge Bankshares (BRBS) signed a definitive all-stock merger with HomeTrust Bancshares (HTBI). Blue Ridge shareholders will receive 0.086 HomeTrust shares per Blue Ridge share, with cash for fractional shares. Boards approved unanimously; closing is expected in Q1 2027 pending approvals. The deal includes an $18.0 million termination fee and supporting voting and warrant-conversion agreements.

tradingview.com4 min

JUL 28

$BRBSMed

Blue Ridge Bankshares, Inc. Announces 2026 Second Quarter Results

Blue Ridge Bankshares (NYSE American: BRBS) reported a Q2 2026 net loss of $0.2 million, or $0.00 per diluted share, versus net income of $0.8 million in Q1 2026. The quarter included a $2.1 million after-tax credit-loss provision and $0.3 million after-tax severance. Loans grew at a 4% annualized rate; NIM was 2.91%.

prnewswire.com6 min

JUL 28

$BRBSMed

BLUE RIDGE BANKSHARES, INC. (BRBS): Results of Operations and Financial Condition

BLUE RIDGE BANKSHARES, INC. (BRBS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 brbs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Blue Ridge Bankshares, Inc. Announces 2026 Second Quarter Results Loan Growth Returns, Improved Deposit Mix, and Continued Reduction in Operating Expenses RICHMOND, VA, July 28, 2026 /PRNewswire/ -- Blue Ridge Bankshares, Inc

SEC EDGAR 8-K4 min

SEP 8

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min